Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 87 for “"Ewing sarcoma"”.

  1. Heterogeneity in Ewing sarcoma

    <p>Ewing sarcoma, an aggressive primary bone and soft tissue tumour is characterised by the expression of the chimeric transcription factor EWS-FLI1 in 90% of patients. This alters expression of many genes including activation of the Insulin Growth Factor (IGF) pathway via IGFBP3 supression. Phase …

    oxford Repository record for Heterogeneity in Ewing sarcoma (opens in a new tab)

  2. Ewing sarcoma of the pelvis

    … reporting our experience on patients with pelvic Ewing’s Sarcoma treated in the Royal Orthopaedic Oncology Unit. We retrospectively reviewed a series of patients with non-metastatic pelvic Ewing’s sarcoma treated between 1977 and 2009. Patients were classified into three groups according to the …

    greece Repository record for Ewing sarcoma of the pelvis (opens in a new tab)

  3. Targeting EWS/FLI1 activity in ewing sarcoma

    Ewing sarcoma (ES) is the second most frequent bone cancer in childhood. Clinically, ES appears as very aggressive osteolytic tumor with early tendency for development of metastasis. It belongs to the group of small-round-blue-cell tumors and is comprised of largely undifferentiated cells. The …

    zurich

  4. The Mechanism of Aneuploidy Induction in Ewing Sarcoma

    Ewing sarcoma is the second most common bone tumor that arises in adolescence and young adults. Despite tumor resection followed by combined chemotherapy, the recurrence rate of metastasized Ewing sarcoma remains high, displaying a significantly reduced 5-year survival rate compared to patients …

    ku Repository record for The Mechanism of Aneuploidy Induction in Ewing Sarcoma (opens in a new tab)

  5. Systematic multi-omics profiling of Ewing sarcoma cell lines

    100 years after its first description, Ewing sarcoma (EwS), the second most common bone-associated cancer in children and young adults, is still poorly understood. Neither the cell of origin is known, nor the detailed mechanism of expression regulation by the pathognomic fusion oncogene. Similarly, …

    lmu-germany Repository record for Systematic multi-omics profiling of Ewing sarcoma cell lines (opens in a new tab)

  6. LOXHD1 IS AN ONCOFUSION-REGULATED ANTIGEN OF EWING SARCOMA

    Ewing Sarcoma (EwS) is the second most common malignant bone tumor predominantly affecting children, adolescents, and young adults. The hallmark genetic aberration in EwS is characterized by a unique t(11:22) (q24;q12) translocation resulting in the pathognomonic EWSR1::FLI1 fusion oncoprotein. …

    penn Repository record for LOXHD1 IS AN ONCOFUSION-REGULATED ANTIGEN OF EWING SARCOMA (opens in a new tab)

  7. Identification of EWS-FLI1 Regions Necessary for Ewing Sarcoma Proliferation

    Ewing sarcoma is pediatric bone malignancy defined by a translocation between EWS and ETS family transcription factor. EWS-FLI1 (EF) is the most common translocation and codes for a novel transcription factor that combines the N-terminus of EWS, which contains LC domain comprised of tyrosine rich …

    utswmed Repository record for Identification of EWS-FLI1 Regions Necessary for Ewing Sarcoma Proliferation (opens in a new tab)

  8. Mechanism of action of Viscum album L. extracts in Ewing sarcoma

    Ewing sarcoma is the second most common bone cancer in children and adolescents. It has a poor prognosis and outcome. Therefore, drug discovery of new anti-tumor agents is still crucial to improve survival of Ewing sarcoma patients. Combining active substances may be beneficial since some drug …

    fu-berlin Repository record for Mechanism of action of Viscum album L. extracts in Ewing sarcoma (opens in a new tab)

  9. Mutation Evolution and Genomic Patterns of Recurrence in Ewing Sarcoma and Leiomyosarcoma

    Sarcomas are a highly heterogeneous group of tumours of the bone and soft tissue whose mutation evolution has been unexplored in the majority of subtypes. From a molecular perspective, sarcomas are sub-classified in two categories: (1) those with disease-defining genetic alterations (commonly …

    toronto-retro Repository record for Mutation Evolution and Genomic Patterns of Recurrence in Ewing Sarcoma and Leiomyosarcoma (opens in a new tab)

  10. Endoglin in Ewing sarcoma: from the biological relevance to a clinical strategy

    … ENG was identified in patient samples from Ewing sarcoma (ES), a bone/soft tissue neoplasia with a putative MSC origin. ES is a predominant paediatric malignancy with high incidence of metastasis at diagnosis, around 30% patients, associated with poor prognosis. This scenario is worsened by …

    sevilla Repository record for Endoglin in Ewing sarcoma: from the biological relevance to a clinical strategy (opens in a new tab)

  11. Molecular Characterization of the Ewing Sarcoma Oncoprotein: Functional Interactions and Therapeutic Potential

    Ewing sarcoma is an aggressive bone cancer with the driving mutation EWS-FLI1 present in 85% of cases, and the remaining 15% attributed to several other mutations including EWS-ETV1. Critically, the EWS portion of these proteins contains an LC domain, which enables it to undergo LLPS and reversibly …

    arizona-thes Repository record for Molecular Characterization of the Ewing Sarcoma Oncoprotein: Functional Interactions and Therapeutic Potential (opens in a new tab)

  12. Treatment of Ewing sarcoma family of tumours through the pharmacological activation of p53.

    Sarcomas constitute a diverse heterogeneous group of solid bone and soft tissue malignancies of mesenchymal origin. It is estimated that sarcomas account for approximately 15% of all paediatric and 1% of all adult cancers, with 200,000 new cases reported worldwide each year. To date 60 distinct …

    adelaide Repository record for Treatment of Ewing sarcoma family of tumours through the pharmacological activation of p53. (opens in a new tab)

  13. Understanding Genome Instability in Ewing Sarcoma: from Molecular Mechanisms to Novel Therapeutic Approaches

    Ewing sarcoma (EwS) is an aggressive mesenchymal neoplasm mainly occurring in children, adolescents and young adults. It is characterized by fusion proteins involving EWSR1 and a member of the ETS family of transcription factors, mainly FLI1 (85% of the cases). Although 5-year survival for patients …

    sevilla Repository record for Understanding Genome Instability in Ewing Sarcoma: from Molecular Mechanisms to Novel Therapeutic Approaches (opens in a new tab)

  14. Identifying CDK8/19 as a Novel Regulator of EWS-FLI1 Function in Ewing Sarcoma

    Ewing sarcoma, a pediatric bone cancer, is characterized by the translocation of the Low Complexity (LC) domain from an RNA binding protein (EWSR1, FUS, or TAF15) with the DNA binding domain of an ETS transcription factor. The translocation EWS-FLI1 accounts for 90% of Ewing sarcoma tumors and a …

    utswmed Repository record for Identifying CDK8/19 as a Novel Regulator of EWS-FLI1 Function in Ewing Sarcoma (opens in a new tab)

Page 1 of 5